×

Get the Prostate Cancer Patient Guide, available as a free emailed pdf.

Go here to learn more or to get a mailed copy.

Session 8: Investigating the Path from PI3K to Protein Synthesis to Tailor Prostate Cancer Therapy

Session 8: Investigating the Path from PI3K to Protein Synthesis to Tailor Prostate Cancer Therapy
29th Annual PCF Scientific Retreat: October 28, 2022 | 5:00 PM – 6:00 PM

Moderator: Daniela Brina, PhD
Institute of Oncology Research, Switzerland

Therapeutic Targeting of the Translational Machinery Blocks MDSCs and Enhances Anti-Tumor Immunity in Prostate Cancer
Daniela Brina, PhD
Institute of Oncology Research, Switzerland

Defining the Therapeutic Selective Dependencies for Distinct Subtypes of PI3K Pathway-Altered Prostate Cancers
Brett Carver, MD
Memorial Sloan Kettering Cancer Center

The Androgen Receptor Regulates a Druggable Translational Regulon in Advanced Prostate Cancer
Andrew Hsieh, MD
Fred Hutchison Cancer Center

80 cents of every dollar donated goes to our prostate cancer research mission

Join the fight against prostate cancer today. Donate